A superior new nasal decongestant; clinical evaluation of tyzine in 675 patients.
D004194:Disease; D006801:Humans; D007093:Imidazoles; D009296:Nasal Cavity; D014663:Nasal Decongestants; D009668:Nose Diseases; D010254:Paranasal Sinus Diseases; D013566:Sympathomimetics / Q000627:therapeutic use*
D007093:Imidazoles; D014663:Nasal Decongestants; D013566:Sympathomimetics; C005810:tetrahydrozoline
NASAL CAVITY/diseases; SYMPATHOMIMETICS/therapeutic use